What is Relay Therapeutics, Inc.'s depreciation?

Relay Therapeutics, Inc. (RLAY) reported depreciation of $504K in Q1 2026.

How has Relay Therapeutics, Inc.'s depreciation changed year-over-year?

Relay Therapeutics, Inc.'s depreciation decreased by 58.3% year-over-year, from $1.21M to $504K.

What is the long-term trend for Relay Therapeutics, Inc.'s depreciation?

Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s depreciation has grown at a -2.4% compound annual growth rate (CAGR), from $3.93M to $3.56M.

Relay Therapeutics, Inc. RLAY Depreciation

Depreciation at other companies

CelcuityCELC

——

Cogent Biosciences, Inc.COGT

——

Tango TherapeuticsTNGX

——

Ionis PharmaceuticalsIONS

——

Jazz PharmaceuticalsJAZZ

——

Other financials

Income statement

See full

Revenue$3.0M-60.9%

Operating income-$78.6M+7.4%

Net income-$73.3M+4.9%

EPS (diluted)-$0.41+10.9%

Balance sheet

See full

Cash & equivalents$204.6M+119%

Total debt$31.6M-33.1%

Total equity$642.2M-10.9%

Total assets$699.6M-12.5%

Cash flow

See full

Operating cash flow-$51.1M+30.2%

CapEx$1.0K—

Free cash flow-$44.9M+22.5%

Valuation

See full

Market cap$3.8B+300%

Profitability

See full

Operating margin-2,776.6%-820pp

Net margin-2,554.1%-745pp

FCF margin-1,536%-429pp

Returns & leverage

See full

Return on equity-40%-4.3pp

Debt / equity0×0.0×

Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s depreciation?: Relay Therapeutics, Inc. (RLAY) reported depreciation of $504K in Q1 2026.
How has Relay Therapeutics, Inc.'s depreciation changed year-over-year?: Relay Therapeutics, Inc.'s depreciation decreased by 58.3% year-over-year, from $1.21M to $504K.
What is the long-term trend for Relay Therapeutics, Inc.'s depreciation?: Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s depreciation has grown at a -2.4% compound annual growth rate (CAGR), from $3.93M to $3.56M.